AHA ACC Lipid Guideline Updates on ASCVD Risk Stratification and Lipoprotein Management

This episode reviews major updates in ASCVD risk stratification and lipid management from the AHA/ACC lipid guideline. Topics include cumulative apolipoprotein B exposure assessment, updated low density lipoprotein cholesterol estimation methods, expanded clinical use of apolipoprotein B and lipoprotein(a), integration of cardiovascular kidney metabolic syndrome into preventive cardiology, revised triglyceride referral thresholds, PREVENT ASCVD risk equations, high sensitivity C-reactive protein guided statin therapy considerations, and the evolving role of coronary artery calcium scoring in refining lipid lowering intensity and individualized cardiovascular risk reduction.